BioCentury | Dec 19, 2019

Benzoxaborole-based CPSF3 inhibitor to treat infections

...Next steps include testing AN3661 in larger animal models. Romark Laboratories L.C. markets Alinia, a pyruvate ferredoxin oxidoreductase...
BioCentury | Dec 5, 2017
Distillery Therapeutics

Cancer

...of CTNNB1 citrullination in additional models of colorectal cancer. Romark Laboratories L.C. markets Alinia, a pyruvate ferredoxin oxidoreductase...
BioCentury | Nov 15, 2010
Clinical News

Alinia nitazoxanide: Pilot trial data

...Fla. Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan Product: Alinia nitazoxanide Business: Infectious Molecular target: Pyruvate ferredoxin oxidoreductase...
BioCentury | Nov 1, 2010
Clinical News

Alinia nitazoxanide: Phase II start

...Fla. Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan Product: Alinia nitazoxanide Business: Infectious Molecular target: Pyruvate ferredoxin oxidoreductase...
BioCentury | May 3, 2010
Clinical News

Alinia nitazoxanide: Phase II data

...Fla. Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan Product: Alinia nitazoxanide Business: Infectious Molecular target: Pyruvate ferredoxin oxidoreductase...
BioCentury | Feb 8, 2010
Clinical News

Alinia nitazoxanide: Phase II started

...Fla. Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan Product: Alinia nitazoxanide Business: Infectious Molecular target: Pyruvate ferredoxin oxidoreductase...
BioCentury | Jan 7, 2010
Targets & Mechanisms

HCV cache: the list

...Co. Ltd./Johnson & Johnson Marketed for gastric ulcers and gastroesophageal reflux disease (GERD) Alinia nitazoxanide Pyruvate ferredoxin oxidoreductase...
BioCentury | Feb 23, 2009
Clinical News

Controlled release nitazoxanide: Phase II data

...Kong. Romark Laboratories L.C. , Tampa, Fla. Product: Controlled release nitazoxanide Business: Infectious Molecular target: Pyruvate ferredoxin oxidoreductase...
BioCentury | Feb 23, 2009
Clinical News

Controlled release nitazoxanide: Phase I data

...Kong. Romark Laboratories L.C. , Tampa, Fla. Product: Controlled release nitazoxanide Business: Infectious Molecular target: Pyruvate ferredoxin oxidoreductase...
BioCentury | Nov 10, 2008
Clinical News

Alinia nitazoxanide: Phase II data

...and Copegus. Romark Laboratories L.C. , Tampa, Fla. Product: Alinia nitazoxanide Business: Infectious Molecular target: Pyruvate ferredoxin oxidoreductase...
Items per page:
1 - 10 of 23